Outlook Therapeutics, Inc..
OTLK.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Outlook Therapeutics, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing ONS-5010, an ophthalmic formulation of bevacizumab for various ophthalmic indications. Bevacizumab is an anti-VEGF (Vascular Endothelial Growth Factor) product. The company's primary focus ...Show More
Better Health for All
0
No evidence available to assess Outlook Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Outlook Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Both articles explicitly state that data on living wage, CEO-to-median-employee pay ratio, collective bargaining, safety incidents, pay equity, worker engagement, turnover, labor violations, insecure contracts, and health insurance coverage is unavailable or not provided.
1
Fair Trade & Ethical Sourcing
0
No information regarding fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical sourcing clauses in contracts, materials risk index, or supplier diversity spend for Outlook Therapeutics, Inc. was found in the provided articles.
1
Honest & Fair Business
0
No evidence available to assess Outlook Therapeutics, Inc. on Honest & Fair Business.
Kind to Animals
0
While one article notes that the company engages in animal testing, no further details are provided regarding the extent of this testing, specific policies, or any other animal welfare practices.
1
Consequently, there is insufficient specific, concrete data to score any of the KPIs against the provided rubric thresholds.
No War, No Weapons
0
No evidence available to assess Outlook Therapeutics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
Outlook Therapeutics, Inc. has an ESG risk score of 38, categorized as "Severe" by finance.yahoo.com, and Sustainalytics rates its ESG risk as high (38.1), noting weak management of ESG material risk.
1
However, the provided articles do not contain any specific quantitative environmental metrics, details on planet-friendly business practices, or concrete evidence to score any of the defined KPIs.
Respect for Cultures & Communities
0
No evidence available to assess Outlook Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-40
Outlook Therapeutics' privacy policy states that sensitive information, such as credit card numbers, is protected by encryption protocols.
1
The company mentions compliance with GDPR and CCPA.
2
Users can access, update, or delete their data through account settings, but some actions require direct contact, indicating some friction.
3
Data is retained only as long as necessary for the purpose of collection.
4
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles for any of the Key Performance Indicators related to Zero Waste & Sustainable Products. The articles primarily discuss regulatory updates, financial filings, and general ESG risk ratings, explicitly stating the absence of information on waste diversion, product recyclability, packaging sustainability, or other relevant metrics.
1